D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 3, 2010, Pages 346-351

  Pollack, Alexia E ^a   Thomas, Lindsay I ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

D1; D2; Dopamine; Fos; Priming; Quinpirole; Rotational behavior; Sensitization; SKF38393; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; OXIDOPAMINE; PROTEIN FOS; QUINPIROLE; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHEMOSENSITIZATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DATA ANALYSIS; DRUG DOSE COMPARISON; DRUG MECHANISM; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE AGONISTS; MALE; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

ANIMALIA; RATTUS;

EID: 71849097957     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.09.016     Document Type: Article

References (33)

1. Asin K.E., Bednarz L., Nikkel A., and Perner R. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa. J Pharmacol Exp Ther 273 (1995) 1483-1490
2. Asin K.E., and Wirtshafter D. Effects of repeated D1 receptor stimulation on rotation and c-fos expression. Eur J Pharmacol 235 (1993) 167-168
3. Barone P., Morelli M., Popolo M., Cicarelli G., Campanella G., and Di Chiara G. Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation. Neurosci 61 (1994) 867-873
4. Berthet A., Porras G., Doudnikoff E., Stark H., Cador M., Bezard E., et al. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesias. J Neurosci 29 (2009) 4829-4835
5. Carey R.J. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res 568 (1991) 205-214
6. Crocker S.J., Morelli M., Wigle N., Nakabeppu Y., and Robertson G.S. D1-receptor-related priming is attenuated by antisense-mediated 'knockdown' of fosB expression. Mol Brain Res 53 (1998) 69-77
7. Engber T.M., Marin C., Susel Z., and Chase T.N. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Eur J Pharmacol 236 (1993) 285-293
8. Fiorentini C., Rizzetti M.C., Busi C., Bontempi S., Collo G., Spano P., et al. Loss of synaptic D1 dopamine/N-methyl-d-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesias in the rat. Mol Pharmacol 69 (2006) 805-812
9. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
10. Gerfen C.R., Miyachi S., Paletzki R., and Brown P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci 22 (2002) 5042-5054
11. Guigoni C., Doudnikoff E., Li Q., Bloch B., and Bezard E. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis 26 (2007) 452-463
12. Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626 (1993) 167-174
13. Huang K.-X., and Walters J.R. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. Neuroscience 75 (1996) 757-775
14. Kashihara K., Akiyama K., Ishihara T., Shiro Y., and Shohmori T. Levodopa but not bromocriptine induces AP-1 and CREB DNA-binding activity in the dopamine-depleted striatum of the rat. Life Sci 58 (1996) 159-170
15. Le Moine C., and Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355 (1995) 418-426
16. Lu L., Koya E., Zhai H., Hope B., and Shaham Y. Role of ERK in cocaine addiction. Trends Neurosci 29 (2006) 695-703
17. Morelli M., and Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Eur J Pharmacol 141 (1987) 101-107
18. Morelli M., Fenu S., Garau L., and Di Chiara G. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162 (1989) 329-335
19. Nadjar A., Gerfen C.R., and Bezard E. Priming for L-dopa-induced dyskinesias in Parkinson's disease: a feature inherent to the treatment or the disease?. Prog Neurobiol 87 (2009) 1-9
20. Obeso J.A., Rodriguez-Oroz M.C., Benitez-Temino B., Blesa F.J., Guridi J., Marin C., et al. Functional organization of the basal ganglia: therapeutic implications for Parkinson's Disease. Mov Disord 23 (2008) S548-S559
21. Paul M.L., Currie R.W., and Robertson H.A. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate early gene activity. Neuroscience 66 (1995) 347-359
22. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press, San Diego
23. Pollack A.E., and Strauss J.B. Time dependence and role of N-methyl-d-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Brain Res 827 (1999) 160-168
24. Pollack A.E., Turgeon S.M., and Fink J.S. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine rats. Neuroscience 79 (1997) 79-93
25. Pollack A.E., and Yates T.M. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine lesioned rats. Neuroscience 94 (1999) 504-514
26. Robertson G.S., Vincent S.R., and Fibiger H.C. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res 523 (1990) 288-290
27. Robertson G.S., Vincent S.R., and Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49 (1992) 285-296
28. Robertson H.A., Peterson M.R., Murphy K., and Robertson G.S. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res 503 (1989) 346-349
29. Rouillard C., Bedard P., Falardeau R., and Di Paolo T. Repeated stimulation of D1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Eur J Pharmacol 157 (1988) 125-133
30. Taverna S., Ilijic E., and Surmeier D.J. Recurrent collateral connection of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28 (2008) 5504-5512
31. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 69-93
32. Vallone D., Pellecchia M.T., Morelli M., Verde P., DiChiara G., and Barone P. Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes in AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. Mol Brain Res 52 (1997) 307-317
33. Wirtshafter D. Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822. Pharmacol Biochem Behav 86 (2007) 505-510